With Academic Collaborators, GSK To Plug For ‘Electroceuticals’

GlaxoSmithKline will fund nonprofit labs across several biomedical and engineering disciplines and offer a $1 million cash prize to probe the role of neural activity in disease. The goal is to build new devices that treat a range of diseases “in their own electrical language.”

Do a web search for the term “electroceuticals,” and many of the results tout a form of alternative medicine. GlaxoSmithKline PLC is angling to make the term a lot more mainstream.

A new funding initiative from the drug giant aims to back academic scientists who are trying to answer early questions about the possibility of using extremely focused electrical impulses to...

More from Combination Products

More from Device Area